SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,909.68 -325.78
( -0.42%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

94348

INE1BZN01016

58.5748291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CURIS

12.86

89.09

EPS(TTM)

Face Value()

Div & Yield %

8.57

Back

ICICI Lombard General Insurance Company standalone net profit declines 46.03% in the June 2026 quarter

Jul 16,2026

Net profit of ICICI Lombard General Insurance Company declined 46.03% to Rs 403.17 crore in the quarter ended June 2026 as against Rs 747.08 crore during the previous quarter ended June 2025. Sales rose 15.85% to Rs 5950.04 crore in the quarter ended June 2026 as against Rs 5136.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5950.04	5136.09	16
OPM %	8.77	19.10	-
PBDT	535.70	993.71	-46
PBT	535.70	993.71	-46
NP	403.17	747.08	-46

76,909.68 -325.78 ( -0.42%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)